| Date Filed | Type | Description |
| 04/21/2022 |
SC 13D/A
| Lowdell Mark William reports a 11.1% stake in INMUNE BIO INC. |
| 03/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2021 |
4
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 701 shares
@ $20, valued at
$14k
|
|
| 10/29/2021 |
4
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 2,357 shares
@ $20, valued at
$47.1k
|
|
| 10/26/2021 |
4
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Sold 400 shares
@ $20, valued at
$8k
|
|
| 07/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/27/2019 |
4
| Lowdell Mark William (10% Owner) has filed a Form 4 on Inmune Bio, Inc.|
Txns:
| Granted 180,000 options
@ $3.91, valued at
$703.8k
|
|
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/08/2019 |
3
| Lowdell Mark William (Chief Scientific Officer) has filed a Form 3 on Inmune Bio, Inc. |